FI963073A0 - Makrosykliset difluorisatonijohdannaiset, jotka ovat käyttökelpoisia viruksia vastustavina aineina - Google Patents

Makrosykliset difluorisatonijohdannaiset, jotka ovat käyttökelpoisia viruksia vastustavina aineina

Info

Publication number
FI963073A0
FI963073A0 FI963073A FI963073A FI963073A0 FI 963073 A0 FI963073 A0 FI 963073A0 FI 963073 A FI963073 A FI 963073A FI 963073 A FI963073 A FI 963073A FI 963073 A0 FI963073 A0 FI 963073A0
Authority
FI
Finland
Prior art keywords
pct
useful
hiv
antiviral agents
macrocyclic
Prior art date
Application number
FI963073A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963073A (fi
Inventor
Robert A Farr
Brent L Podlogar
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of FI963073A0 publication Critical patent/FI963073A0/fi
Publication of FI963073A publication Critical patent/FI963073A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI963073A 1994-02-04 1996-08-02 Makrosykliset difluorisatonijohdannaiset, jotka ovat käyttökelpoisia viruksia vastustavina aineina FI963073A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19208094A 1994-02-04 1994-02-04
PCT/US1994/013711 WO1995021186A1 (en) 1994-02-04 1994-11-28 Macrocyclic difluorostatone derivatives useful as antiviral agents

Publications (2)

Publication Number Publication Date
FI963073A0 true FI963073A0 (fi) 1996-08-02
FI963073A FI963073A (fi) 1996-08-02

Family

ID=22708156

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963073A FI963073A (fi) 1994-02-04 1996-08-02 Makrosykliset difluorisatonijohdannaiset, jotka ovat käyttökelpoisia viruksia vastustavina aineina

Country Status (20)

Country Link
US (1) US5969132A (no)
EP (1) EP0742791B1 (no)
JP (1) JP3574455B2 (no)
KR (1) KR100367379B1 (no)
CN (1) CN1142830A (no)
AT (1) ATE198602T1 (no)
AU (1) AU684875B2 (no)
CA (1) CA2182476C (no)
DE (1) DE69426574T2 (no)
DK (1) DK0742791T3 (no)
ES (1) ES2155515T3 (no)
FI (1) FI963073A (no)
GR (1) GR3035623T3 (no)
HU (1) HUT74384A (no)
IL (1) IL112514A0 (no)
NO (1) NO963254L (no)
NZ (1) NZ277410A (no)
PT (1) PT742791E (no)
WO (1) WO1995021186A1 (no)
ZA (1) ZA95756B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4928261B2 (ja) 2003-06-18 2012-05-09 トランザイム・ファーマ・インコーポレイテッド モチリン受容体の大環状拮抗薬

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH672792A5 (no) * 1985-02-19 1989-12-29 Sandoz Ag
DE3674131D1 (de) * 1985-04-19 1990-10-18 Upjohn Co Substituierte dihalo-statin-reninhemmungsmittel.
HUT58764A (en) * 1988-07-08 1992-03-30 Smithkline Beckman Corp Process for producing peptides, pharmaceutical compositions containing them and amino-acid intermediates
US5071837A (en) * 1990-11-28 1991-12-10 Warner-Lambert Company Novel renin inhibiting peptides
HU210647B (en) * 1991-01-02 1995-06-28 Merrell Dow Pharma Process for producing antiviral difluoro-statone derivatives and pharmaceutical compositions containing them
JPH10505582A (ja) * 1994-07-15 1998-06-02 メリル・フアーマシユウテイカルズ・インコーポレイテツド ジフルオロスタトン抗ウイルス剤

Also Published As

Publication number Publication date
IL112514A0 (en) 1995-05-26
ATE198602T1 (de) 2001-01-15
AU684875B2 (en) 1998-01-08
EP0742791A1 (en) 1996-11-20
ES2155515T3 (es) 2001-05-16
CA2182476C (en) 2000-12-26
DE69426574D1 (de) 2001-02-15
ZA95756B (en) 1995-10-05
NO963254D0 (no) 1996-08-02
HU9602158D0 (en) 1996-09-30
DK0742791T3 (da) 2001-04-02
EP0742791B1 (en) 2001-01-10
NZ277410A (en) 1997-02-24
WO1995021186A1 (en) 1995-08-10
CN1142830A (zh) 1997-02-12
DE69426574T2 (de) 2001-08-09
GR3035623T3 (en) 2001-06-29
HUT74384A (en) 1996-12-30
NO963254L (no) 1996-08-02
FI963073A (fi) 1996-08-02
PT742791E (pt) 2001-06-29
KR100367379B1 (ko) 2003-04-11
JP3574455B2 (ja) 2004-10-06
US5969132A (en) 1999-10-19
JPH09508417A (ja) 1997-08-26
AU1262295A (en) 1995-08-21

Similar Documents

Publication Publication Date Title
ES2139195T3 (es) Derivados de sulfonamidas como inhibidores de la aspartil-proteasa.
BG102048A (en) Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
WO1990015066A3 (fr) Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in vitro des infections dues a ces virus
BR9607543A (pt) Inibidores de protease retroviral sulfonamida hidroxietilamino de bis-amino ácido
ATE315667T1 (de) Amplifizierung und detektion von hiv-1 und/oder hiv-2
BR9607450A (pt) Inibidores de protease retroviral sulfonilalcanoilamino hidroxietilamino sulfonamida
HUP0202502A2 (hu) Virális fertőzőképességet blokkoló peptidek és eljárások ezek alkalmazására
BR9607625A (pt) Inibidores de protease retroviral sulfonamida hidroxietilamino de aminoácido heterociclocarbonila
MX9700414A (es) Agentes antivirales de difluoroestatona.
ES2103577T3 (es) Compuestos antiviricos de naftoquinona, composiciones que los contienen y utilizaciones de estos compuestos.
FI963073A0 (fi) Makrosykliset difluorisatonijohdannaiset, jotka ovat käyttökelpoisia viruksia vastustavina aineina
UA41338C2 (uk) Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
MXPA04004061A (es) Derivados de quinolina y piridina antiretrovirales.

Legal Events

Date Code Title Description
MA Patent expired